ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Detecting Critical Functional Ingredients Group and Mechanism of Xuebijing Injection in Treating Sepsis

Qi-Wu; Yin, Chuan-hui; Li, Yi; Cai, Jie-qi; Yang, Han-yun; Huang, Ying-ying; Zheng, Yi-xu; Xiong, Ke; Yu, Hai-lang; Lu, Ai-ping*; Wang, Ke-xin*; Guan, Dao-gang*; Chen, Yu-peng*南方医科大学; 1
Frontiers in Pharmacology2021-12-6DOI: 10.3389/fphar.2021.769190
2被引20阅读
引用收藏
分享

摘要

Sepsis is a systemic inflammatory reaction caused by various infectious or noninfectious factors, which can lead to shock, multiple organ dysfunction syndrome, and death. It is one of the common complications and a main cause of death in critically ill patients. At present, the treatments of sepsis are mainly focused on the controlling of inflammatory response and reduction of various organ function damage, including anti-infection, hormones, mechanical ventilation, nutritional support, and traditional Chinese medicine (TCM). Among them, Xuebijing injection (XBJI) is an important derivative of TCM, which is widely used in clinical research. However, the molecular mechanism of XBJI on sepsis is still not clear. The mechanism of treatment of "bacteria, poison and inflammation" and the effects of multi-ingredient, multi-target, and multi-pathway have still not been clarified. For solving this issue, we designed a new systems pharmacology strategy which combines target genes of XBJI and the pathogenetic genes of sepsis to construct functional response space (FRS). The key response proteins in the FRS were determined by using a novel node importance calculation method and were condensed by a dynamic programming strategy to conduct the critical functional ingredients group (CFIG). The results showed that enriched pathways of key response proteins selected from FRS could cover 95.83% of the enriched pathways of reference targets, which were defined as the intersections of ingredient targets and pathogenetic genes. The targets of the optimized CFIG with 60 ingredients could be enriched into 182 pathways which covered 81.58% of 152 pathways of 1,606 pathogenetic genes. The prediction of CFIG targets showed that the CFIG of XBJI could affect sepsis synergistically through genes such as TAK1, TNF-alpha, IL-1 beta, and MEK1 in the pathways of MAPK, NF-kappa B, PI3K-AKT, Toll-like receptor, and tumor necrosis factor signaling. Finally, the effects of apigenin, baicalein, and luteolin were evaluated by in vitro experiments and were proved to be effective in reducing the production of intracellular reactive oxygen species in lipopolysaccharide-stimulated RAW264.7 cells, significantly. These results indicate that the novel integrative model can promote reliability and accuracy on depicting the CFIGs in XBJI and figure out a methodological coordinate for simplicity, mechanism analysis, and secondary development of formulas in TCM.

学科与关键词

关键词
Xuebijing injection (XBJI)sepsisnetwork pharmacologyfunctional response spacecritical functional ingredients groupkey response proteins
相关
加载中…
  • Effect of an Herbal-Based Injection on 28-Day Mortality in Patients With Sepsis The EXIT-SEP Randomized Clinical Trial
    Liu, Songqiao; Yao, Chen; Xie, Jianfeng; Liu, Hong; Wang, Hongliang; Lin, Zhaofen; Qin, Bingyu; Wang, Difen; Lu, Weihua; Ma, Xiaochun; Liu, Yan; Liu, Ling; Zhang, Chi; Xu, Lei; Zheng, Ruiqiang; Zhou, Feihu; Liu, Zhongmin; Zhang, Guoqiang; Zhou, Lixin; Liu, Jian; Fei, Aihua; Zhang, Guoxiu; Zhu, Yimin; Qian, Kejian; Wang, Ruilan; Liang, Yafeng; Duan, Meili; Wu, Dawei; Sun, Rongqing; Wang, Ying; Zhang, Xijing; Cao, Quan; Yang, Mingshi; Jin, Minggen; Song, Yan; Huang, Ling; Zhou, FachunJAMA Internal Medicine, 2023, 183(7): 647-655.被引 9
  • Exploring the efficacious constituents and underlying mechanisms of sini decoction for sepsis treatment through network pharmacology and multi-omics
    Gu, Yang; Li, Ziying; Li, Han; Yi, Xiaoling; Liu, Xun; Zhang, Yan; Gong, Shu*; Yu, Tao*; Li, Li*PHYTOMEDICINE, 2024, 123: 155212.被引 1
  • Network pharmacology prediction and molecular docking-based strategy to explore the potential mechanism of Huanglian Jiedu Decoction against sepsis
    Li, Xing; Wei, Shizhang; Niu, Shengqi; Ma, Xiao; Li, Haotian; Jing, Manyi; Zhao, Yanling*Computers in Biology and Medicine, 2022, 144: 105389.被引 106
查看全部 →

发表信息

论文状态
公开发表
期刊
Frontiers in Pharmacology
发表日期
2021-12-06
卷期
第 12 卷
页码
769190
DOI
10.3389/fphar.2021.769190
语言
ENGLISH
期刊收录
NSL
期刊等级
2区
成果收录
SCIE
资助标注
Startup fund from Southern Medical University [G619280010]; Natural Science Foundation Council of China [32070676, 31501080]; National Key R&D Program of China [2018YFC1705205]; Natural Science Foundation of Guangdong Province [2021A1515010737]; Hong Kong Baptist University Strategic Development Fund [SDF13-1209-P01, SDF15-0324-P02, SDF19-0402-P02]; Hong Kong Baptist University Interdisciplinary Research Matching Scheme [RC/IRCs/17-18/04]

作者

  • Q

    Qi-Wu (第一作者)

    southern med univ

  • Y

    Yin, Chuan-hui

    southern med univ

查看全部 13 位作者收起作者
  • L

    Li, Yi

    southern med univ

  • C

    Cai, Jie-qi

    southern med univ

  • Y

    Yang, Han-yun

    1 · southern med univ

  • H

    Huang, Ying-ying

    southern med univ

  • Z

    Zheng, Yi-xu

    southern med univ

  • X

    Xiong, Ke

    southern med univ

  • Y

    Yu, Hai-lang

    southern med univ

  • L

    Lu, Ai-ping (通讯)

    hong kong baptist univ

  • W

    Wang, Ke-xin (通讯)

    southern med univ

  • G

    Guan, Dao-gang (通讯)

    southern med univ

  • C

    Chen, Yu-peng (通讯)

    southern med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417